The 2025 impact factor for Journal for Immunotherapy of Cancer is 10.6. The 5-year impact factor is 11.5. The journal is listed as JCR Q1 in the current Journal Metrics dataset.
Use this record to check the journal title, ISSN, JCR quartile, CAS block, publisher details, and similar journals before comparing publication venues.
If you searched for Journal for Immunotherapy of Cancer impact factor 2025, compare this exact title record with the journal homepage and nearby journals in the same field. That helps avoid mixing this journal with a similarly named title, abbreviation, society series, or outdated metric snippet.
This page is designed for exact-title searches such as Journal for Immunotherapy of Cancer impact factor 2025. First confirm that the ISSN and title match this record before using the metric in a journal shortlist or submission decision.
For high-stakes submission decisions, verify the title against the publisher record, Clarivate's Master Journal List or Journal Citation Reports if you have access, and the context in our methodology. Treat the 5-year impact factor, JCR quartile, article volume, and similar journals as supporting context rather than a single-number publication decision.
Ranked #10 in Oncology by impact factor and #10 among Q1 Oncology journals. This context helps compare Journal for Immunotherapy of Cancer against journals publishing in the same field.
See if your manuscript fits this journal's recent focus before you commit to a shortlist.